Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes

MLA

Maddaloni, Ernesto, et al. Association of Osteocalcin, Osteoprotegerin, and Osteopontin with Cardiovascular Disease and Retinopathy in Type 2 Diabetes. Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..118386da0483e056bd7e23febb2ad53d&authtype=sso&custid=ns315887.

APA

Maddaloni, E., Coraggio, L., Amendolara, R., Baroni, M. G., Cavallo, M. G., Copetti, M., Cossu, E., D’Angelo, P., D’Onofrio, L., Cosmo, S. D., Leonetti, F., Morano, S., Morviducci, L., Napoli, N., Prudente, S., Pugliese, G., Park, K., Holman, R. R., Trischitta, V., & Buzzetti, R. (2023). Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.

Chicago

Maddaloni, Ernesto, Lucia Coraggio, Rocco Amendolara, Marco G Baroni, Maria G Cavallo, Massimiliano Copetti, Efisio Cossu, et al. 2023. “Association of Osteocalcin, Osteoprotegerin, and Osteopontin with Cardiovascular Disease and Retinopathy in Type 2 Diabetes,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..118386da0483e056bd7e23febb2ad53d&authtype=sso&custid=ns315887.